Ruth Vera

3.9k total citations
81 papers, 2.0k citations indexed

About

Ruth Vera is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruth Vera has authored 81 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 24 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruth Vera's work include Colorectal Cancer Treatments and Studies (29 papers), Colorectal Cancer Surgical Treatments (23 papers) and Colorectal and Anal Carcinomas (16 papers). Ruth Vera is often cited by papers focused on Colorectal Cancer Treatments and Studies (29 papers), Colorectal Cancer Surgical Treatments (23 papers) and Colorectal and Anal Carcinomas (16 papers). Ruth Vera collaborates with scholars based in Spain, United States and United Kingdom. Ruth Vera's co-authors include Hugo Arasanz, Grazyna Kochan, David Escors, Miren Zuazo, María Gato, María Jesús García-Granda, Jorge Aparicio, Vicente Alonso, Carles Pericay and Carlos Fernández-Martos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Ruth Vera

75 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Vera Spain 20 1.6k 708 502 328 213 81 2.0k
Ruth Vera Spain 24 1.3k 0.8× 357 0.5× 347 0.7× 394 1.2× 252 1.2× 102 1.8k
Michael Ong Canada 17 1.1k 0.7× 562 0.8× 247 0.5× 451 1.4× 362 1.7× 89 1.8k
Roisin E. O’Cearbhaill United States 25 1.2k 0.8× 472 0.7× 446 0.9× 348 1.1× 471 2.2× 174 2.4k
Russell C. Langan United States 18 1.4k 0.9× 453 0.6× 718 1.4× 314 1.0× 365 1.7× 62 2.1k
Miso Kim South Korea 25 1.2k 0.8× 248 0.4× 276 0.5× 710 2.2× 292 1.4× 87 1.7k
Jaekyung Cheon South Korea 22 720 0.5× 487 0.7× 198 0.4× 365 1.1× 166 0.8× 92 1.4k
Aurélie Bertaut France 24 838 0.5× 330 0.5× 303 0.6× 590 1.8× 357 1.7× 105 1.8k
C.J.H. van de Velde Netherlands 21 788 0.5× 604 0.9× 117 0.2× 389 1.2× 109 0.5× 39 1.5k
Kristine Zanotti United States 28 614 0.4× 434 0.6× 156 0.3× 225 0.7× 361 1.7× 68 2.4k
Maria Rosaria Valerio Italy 21 745 0.5× 308 0.4× 154 0.3× 310 0.9× 186 0.9× 94 1.4k

Countries citing papers authored by Ruth Vera

Since Specialization
Citations

This map shows the geographic impact of Ruth Vera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Vera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Vera more than expected).

Fields of papers citing papers by Ruth Vera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Vera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Vera. The network helps show where Ruth Vera may publish in the future.

Co-authorship network of co-authors of Ruth Vera

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Vera. A scholar is included among the top collaborators of Ruth Vera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Vera. Ruth Vera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montagut, Clara, Joana Vidal, Vicente Alonso-Orduña, et al.. (2025). LBA33 Circulating tumor (ct) DNA-guided anti-EGFR rechallenge strategy in metastatic colorectal cancer (mCRC): Final results of the phase II randomized CITRIC trial. Annals of Oncology. 36. S1576–S1577.
2.
Chocarro, Luisa, Ester Blanco, Leticia Fernández, et al.. (2024). PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO Molecular Medicine. 16(8). 1791–1816. 11 indexed citations
3.
Suárez, Javier, María Alsina, N. Castro Unanua, et al.. (2024). Higher rate of pathologic complete response in patients with early-onset locally advanced rectal cancer. SHILAP Revista de lepidopterología. 3. 100033–100033. 2 indexed citations
4.
Labiano, Ibone, Ana E. Huerta, María Alsina, et al.. (2024). Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma. Scientific Reports. 14(1). 16203–16203. 4 indexed citations
5.
Grávalos, Cristina, Fernando Pereira, Ruth Vera, et al.. (2023). Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement. Clinical & Translational Oncology. 25(12). 3378–3394. 2 indexed citations
6.
Vera, Ruth, et al.. (2023). Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach. Clinical & Translational Oncology. 25(7). 2069–2076. 16 indexed citations
7.
Arasanz, Hugo, Luisa Chocarro, Leticia Fernández, et al.. (2023). Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International Journal of Molecular Sciences. 24(12). 9855–9855. 6 indexed citations
8.
Chocarro, Luisa, Hugo Arasanz, Leticia Fernández, et al.. (2022). CAR-T Cells for the Treatment of Lung Cancer. Life. 12(4). 561–561. 14 indexed citations
9.
Arasanz, Hugo, Ana Bocanegra, Idoia Morilla, et al.. (2022). Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer. Cancers. 14(16). 3846–3846. 26 indexed citations
10.
Aranda, Enrique, Élena Elez, Pilar García‐Alfonso, et al.. (2021). Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept. Clinical & Translational Oncology. 23(8). 1520–1528. 6 indexed citations
11.
Carrato, Alfredo, L. Cerezo, Jaime Feliú, et al.. (2021). Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clinical & Translational Oncology. 24(1). 112–126. 20 indexed citations
12.
Zuazo, Miren, Hugo Arasanz, Ana Bocanegra, et al.. (2020). Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy. Frontiers in Immunology. 11. 586907–586907. 54 indexed citations
13.
Zuazo, Miren, Hugo Arasanz, G. Fernández-Hinojal, et al.. (2019). Functional systemic CD 4 immunity is required for clinical responses to PD ‐L1/ PD ‐1 blockade therapy. EMBO Molecular Medicine. 11(7). e10293–e10293. 143 indexed citations
14.
Bocanegra, Ana, G. Fernández-Hinojal, Hugo Arasanz, et al.. (2019). PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer. International Journal of Molecular Sciences. 20(7). 1631–1631. 62 indexed citations
15.
Escors, David, María Gato, Miren Zuazo, et al.. (2018). The intracellular signalosome of PD-L1 in cancer cells. Signal Transduction and Targeted Therapy. 3(1). 26–26. 215 indexed citations
16.
Arrarás, Juan Ignacio, José Juan Illarramendi, Gemma Asín, et al.. (2018). Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up. The Breast. 41. 74–81. 12 indexed citations
17.
Teijeira, Lucía, et al.. (2017). Regorafenib as third-line treatment for refractory metastatic colorectal cancer (mCRC): Experience of Hospital de Navarra clinical practice. Annals of Oncology. 28. iii109–iii109. 1 indexed citations
18.
Gato, María, Miren Zuazo, Hugo Arasanz, et al.. (2017). PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. Cell Reports. 20(8). 1818–1829. 223 indexed citations
19.
Arrarás, Juan Ignacio, José Juan Illarramendi, A. Viúdez, et al.. (2012). The cancer outpatient satisfaction with care questionnaire for chemotherapy, OUT-PATSAT35 CT: a validation study for Spanish patients. Supportive Care in Cancer. 20(12). 3269–3278. 15 indexed citations
20.
Felip, Enriqueta, et al.. (1997). Cisplatin and Vinorelbine Followed by Radiotherapy in the Treatment of Stage III-B Non-Small-Cell Lung Cancer Patients. American Journal of Clinical Oncology. 20(4). 404–406. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026